1. Agrimonia coreana Extract Exerts Its Therapeutic Effect through CRAC Channel Inhibition for Atopic Dermatitis Treatment.
- Author
-
Kim J, Lee JM, Park SJ, Nam YR, Choi SW, Nam JH, Kim HJ, and Kim WK
- Subjects
- Animals, Mice, Disease Models, Animal, Calcium Release Activated Calcium Channels metabolism, Calcium Release Activated Calcium Channels antagonists & inhibitors, Humans, Calcium Channel Blockers pharmacology, Calcium Channel Blockers therapeutic use, Calcium Signaling drug effects, T-Lymphocytes drug effects, T-Lymphocytes metabolism, T-Lymphocytes immunology, Dermatitis, Atopic drug therapy, Dermatitis, Atopic metabolism, Dermatitis, Atopic pathology, Plant Extracts pharmacology, Plant Extracts chemistry, Plant Extracts therapeutic use, Agrimonia chemistry
- Abstract
Atopic dermatitis (AD) is a common allergic inflammatory skin condition marked by severe itching, skin lichenification, and chronic inflammation. AD results from a complex immune response, primarily driven by T lymphocytes and environmental triggers, leading to a disrupted epidermal barrier function. Traditional treatments, such as topical corticosteroids, have limitations due to long-term side effects, highlighting the need for safer alternatives. Here, we aimed to show that Agrimonia coreana extract (AC
ext ) can be used in treating AD-related dermatologic symptoms. ACext could inhibit CRAC (Calcium Release-Activated Calcium) channel activity, reducing Orai1/CRAC currents and decreasing intracellular calcium signaling. This inhibition was further confirmed by the reduced IL-2 levels and T cell proliferation upon ACext treatment. In a mouse model of AD, ACext significantly ameliorates symptoms, improves histological parameters, and enhances skin barrier function, demonstrating its potential for treating AD.- Published
- 2024
- Full Text
- View/download PDF